Skip to content

Pain management after immediate implant placement

Application of liposomal bupivacaine in pain management after immediate implant placement

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN90549666
Enrollment
26
Registered
2026-07-27
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain management in patients undergoing immediate dental implant placement (=3 implants) Oral Health

Interventions

Participants were randomly assigned to an experimental group (n=16) and a control group (n=16) using a random number table. The specific steps for randomization and allocation concealment were as foll
2. Allocation Concealment: Based on the random allocation sequence, group information (the experimental group or control group) was placed into sequentially numbered, sealed, and opaque envelopes (SNO
3. Implementation of Randomization: After enrollment, patients were numbered in the order of their inclusion. A surgical assistant sequentially opened the corresponding numbered envelope, assigned the

Sponsors

Changshu Yuhui Dental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. =3 immediate implants with intact socket bone wall 2. Aged 18–70 years, American Society of Anesthesiologists (ASA) I–II 3. No local anaesthetic or nonsteroidal anti-inflammatory drug (NSAID) allergy 4. Complete 72-h follow-up 5. Voluntary informed consent

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or lactating 2. Severe cardiopulmonary, hepatic or renal disease, coagulation disorders or uncontrolled diabetes (fasting blood glucose >8.0 mmol/l) 3. Combined bone grafting and sinus elevation 4. Long-term analgesic or hormone dependence 5. Patients with psychiatric disorders who are unable to cooperate 6. Acute or chronic inflammation of the surgical site

Design outcomes

Primary

MeasureTime frame
Postoperative pain severity measured using the Visual Analogue Scale (VAS) for pain, a 0–10 point scale, at 24 hours postoperatively (24 h after surgery)

Countries

China

Contacts

Public ContactShilei Han
han_shix43319@126.com+86 (0)18852905844

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 25, 2026